Clinical Trials Logo

Cocaine Abuse clinical trials

View clinical trials related to Cocaine Abuse.

Filter by:

NCT ID: NCT01651377 Completed - Substance Abuse Clinical Trials

Pramipexole as a Treatment for Cocaine Dependence

Start date: October 2011
Phase: Phase 1
Study type: Interventional

The purposes of this study are as follows: 1. To assess the cardiovascular and subjective effects of cocaine during treatment with pramipexole and placebo. 2. To assess the reinforcing effects of cocaine, measured using choice procedures, during treatment with pramipexole and placebo.

NCT ID: NCT01651364 Completed - Substance Abuse Clinical Trials

A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence

Start date: July 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the effects of treatment with cabergoline, compared to treatment with placebo, on cocaine induced craving and subjective effects in cocaine-dependent human volunteers.

NCT ID: NCT01601743 Completed - Substance Abuse Clinical Trials

Exercise as a Behavioral Treatment for Cocaine Dependence

Start date: September 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effects of exercise on cocaine use, fitness, and cravings for cocaine and nicotine. This study is part of an effort to develop treatments for cocaine abuse.

NCT ID: NCT01601730 Completed - Substance Abuse Clinical Trials

Modafinil - Escitalopram Study for Cocaine Dependence

Start date: August 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to improve the efficacy of modafinil as a potential treatment for cocaine dependence.

NCT ID: NCT01437293 Completed - Cocaine Abuse Clinical Trials

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)

COST
Start date: August 2010
Phase: Phase 1
Study type: Interventional

An inpatient safety study to characterize the cardiovascular and behavioral effects of cocaine administration in the presence of LCE. The proposed study involves an inpatient stay of 12 days during which participants will have two cocaine-administration sessions, each including five doses of smoked cocaine with ascending doses.

NCT ID: NCT01401270 Completed - Cocaine Abuse Clinical Trials

Prize Contingency Management for Cocaine-Dependent Methadone Patients

Start date: November 2011
Phase: N/A
Study type: Interventional

The investigators will randomize 300 cocaine-dependent methadone patients to 1 of 6 conditions: (a) a control group, (b) a contingency management condition that arranges a 100% probability of winning a prize with each draw and has 3 prize categories, (c) a contingency management condition that arranges a 31% probability of winning and has 3 prize categories, (d) a contingency management condition that arranges a 100% probability of winning and has 7 prize categories, (e) a contingency management condition that arranges a 31% probability of winning and has 7 prize categories, or (f) usual prize contingency management with a 50% probability of winning from 3 prize categories. Magnitudes of reinforcement will be identical across conditions, but lower overall probability conditions arrange for greater chances of winning larger magnitude prizes. The investigators expect that the new contingency management conditions will reduce cocaine use relative to the control condition, that 31% probability conditions will decrease drug use relative to 100% conditions, and that 7-prize category conditions will reduce drug use compared to 3-prize category conditions. In addition, the 31%/7-category condition is expected to be most efficacious. Results will be instrumental for further developing prize contingency management to improve outcomes of cocaine-dependent methadone patients.

NCT ID: NCT01366001 Completed - Cocaine Abuse Clinical Trials

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

Start date: August 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of ALKS33-BUP when administered to opioid-experienced cocaine abusers.

NCT ID: NCT01327586 Completed - Cocaine Dependence Clinical Trials

Abstinence-Linked Money Management Multisite

Start date: December 2009
Phase: Phase 2
Study type: Interventional

Randomized clinical trial comparing a money management-based intervention involving storage and management of client funds, substance abuse counseling, and risk reduction counseling to individualized drug counseling.

NCT ID: NCT01249274 Completed - Cocaine Dependence Clinical Trials

Progesterone for Postpartum Cocaine Relapse

Start date: August 2010
Phase: N/A
Study type: Interventional

The investigators propose a placebo-controlled, randomized clinical trial that would enroll 50 postpartum women with a history of cocaine abuse or dependence to assess whether progesterone (100mgs twice daily) decreases postpartum cocaine use.

NCT ID: NCT01062945 Completed - Substance Abuse Clinical Trials

The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine

Start date: January 2010
Phase: Phase 1
Study type: Interventional

The purpose of the study is to asses the potential interactions between intravenous cocaine and doxazosin in cocaine dependent volunteers who are not seeking treatment. The study will evaluate the effects of doxazosin on the cardiovascular and subjective effects of cocaine in a human laboratory study.